Shares of SciSparc Ltd. (NASDAQ:SPRC – Get Free Report) fell 0.1% during trading on Monday . The company traded as low as $0.6406 and last traded at $0.6832. 93,964 shares changed hands during trading, a decline of 96% from the average session volume of 2,457,542 shares. The stock had previously closed at $0.6840.
SciSparc Stock Down 0.1%
The company has a fifty day moving average of $1.31 and a 200-day moving average of $2.94.
SciSparc (NASDAQ:SPRC – Get Free Report) last announced its earnings results on Tuesday, November 18th. The company reported ($3.08) EPS for the quarter. The business had revenue of $0.23 million during the quarter.
About SciSparc
SciSparc AG is a clinical‐stage medical technology company focused on the development and commercialization of extracorporeal shock wave–based neuromodulation devices. Founded in 2016 and headquartered in Switzerland, the company applies proprietary low‐intensity shock wave technology to noninvasively stimulate neural tissue. SciSparc completed its initial public offering on the NASDAQ in 2021 under the ticker SPRC, securing funding to advance its clinical pipeline.
The company’s lead product, the TR100 system, delivers transcranial shock wave stimulation (tSWS) designed to target areas of the brain associated with motor control and cognitive function.
Recommended Stories
- Five stocks we like better than SciSparc
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.
